APO Research
Talk to an analyst

APO RESEARCH · REPORT

Autoimmune Disease Diagnostics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Autoimmune Disease Diagnostics Market Outlook and Growth Opportunities 2026

20 December 2025215 pages

Choose your research edition.

Industry ResearchAutoimmune Disease Diagnostics Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Autoimmune Disease Diagnostics Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Autoimmune Disease Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autoimmune Disease Diagnostics Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Autoimmune Disease Diagnostics Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Autoimmune Disease Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Autoimmune Disease Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Autoimmune Disease Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Autoimmune Disease Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Autoimmune Disease Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Autoimmune Disease Diagnostics market include Abbott Laboratories, Autoimmune Technologies, Avant Diagnostics, Beckman Coulter, Bio-Rad Laboratories, DiaSorin, ERBA Diagnostics, Euro Diagnostica and EUROIMMUN, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Autoimmune Disease Diagnostics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Autoimmune Disease Diagnostics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Autoimmune Disease Diagnostics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Autoimmune Disease Diagnostics market.

Autoimmune Disease Diagnostics Segment by Company

Abbott Laboratories

Autoimmune Technologies

Avant Diagnostics

Beckman Coulter

Bio-Rad Laboratories

DiaSorin

ERBA Diagnostics

Euro Diagnostica

EUROIMMUN

Exagen Diagnostics

Gold Standard Diagnostics

HOB Diagnostics

HUMAN Diagnostics

Immco Diagnostics

ImmunArray

Inova Diagnostics

Myriad Genetics

Omega Diagnostics

ORGENTEC Diagnostika

Phadia

Protagen

Roche Diagnostics

Siemens Healthcare

Autoimmune Disease Diagnostics Segment by Type

Analyzers

Assay Kits

Autoimmune Disease Diagnostics Segment by Application

Hospitals

Research Laboratories

Autoimmune Disease Diagnostics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Autoimmune Disease Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Autoimmune Disease Diagnostics key companies, revenue, market share, and recent developments.

3. To split the Autoimmune Disease Diagnostics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Autoimmune Disease Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Autoimmune Disease Diagnostics significant trends, drivers, influence factors in global and regions.

6. To analyze Autoimmune Disease Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmune Disease Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autoimmune Disease Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmune Disease Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Autoimmune Disease Diagnostics industry.

Chapter 3: Detailed analysis of Autoimmune Disease Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Autoimmune Disease Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Autoimmune Disease Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Autoimmune Disease Diagnostics Industry Trends Table 2. Autoimmune Disease Diagnostics Industry Drivers Table 3. Autoimmune Disease Diagnostics Industry Opportunities and Challenges Table 4. Autoimmune Disease Diagnostics Industry Restraints Table 5. Global Autoimmune Disease Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Autoimmune Disease Diagnostics Revenue Share by Company (2021-2026) Table 7. Global Autoimmune Disease Diagnostics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Autoimmune Disease Diagnostics Key Company Manufacturing Base & Headquarters Table 9. Global Autoimmune Disease Diagnostics Company, Product Type & Application Table 10. Global Autoimmune Disease Diagnostics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Autoimmune Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Analyzers Table 15. Significant Companies of Assay Kits Table 16. Global Autoimmune Disease Diagnostics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Autoimmune Disease Diagnostics Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Autoimmune Disease Diagnostics Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Autoimmune Disease Diagnostics Sales Value Share by Type (2021-2026) Table 20. Global Autoimmune Disease Diagnostics Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Research Laboratories Table 23. Global Autoimmune Disease Diagnostics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Autoimmune Disease Diagnostics Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Autoimmune Disease Diagnostics Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Autoimmune Disease Diagnostics Sales Value Share by Application (2021-2026) Table 27. Global Autoimmune Disease Diagnostics Sales Value Share by Application (2027-2032) Table 28. Global Autoimmune Disease Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Autoimmune Disease Diagnostics Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Autoimmune Disease Diagnostics Sales Value Share by Region (2021-2026) Table 31. Global Autoimmune Disease Diagnostics Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Autoimmune Disease Diagnostics Sales Value Share by Region (2027-2032) Table 33. Global Autoimmune Disease Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Autoimmune Disease Diagnostics Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Autoimmune Disease Diagnostics Sales Value Market Share by Country (2021-2026) Table 36. Global Autoimmune Disease Diagnostics Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Autoimmune Disease Diagnostics Sales Value Market Share by Country (2027-2032) Table 38. Abbott Laboratories Company Information Table 39. Abbott Laboratories Business Overview Table 40. Abbott Laboratories Autoimmune Disease Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Abbott Laboratories Autoimmune Disease Diagnostics Product Portfolio Table 42. Abbott Laboratories Recent Development Table 43. Autoimmune Technologies Company Information Table 44. Autoimmune Technologies Business Overview Table 45. Autoimmune Technologies Autoimmune Disease Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Autoimmune Technologies Autoimmune Disease Diagnostics Product Portfolio Table 47. Autoimmune Technologies Recent Development Table 48. Avant Diagnostics Company Information Table 49. Avant Diagnostics Business Overview Table 50. Avant Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Avant Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 52. Avant Diagnostics Recent Development Table 53. Beckman Coulter Company Information Table 54. Beckman Coulter Business Overview Table 55. Beckman Coulter Autoimmune Disease Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Beckman Coulter Autoimmune Disease Diagnostics Product Portfolio Table 57. Beckman Coulter Recent Development Table 58. Bio-Rad Laboratories Company Information Table 59. Bio-Rad Laboratories Business Overview Table 60. Bio-Rad Laboratories Autoimmune Disease Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Portfolio Table 62. Bio-Rad Laboratories Recent Development Table 63. DiaSorin Company Information Table 64. DiaSorin Business Overview Table 65. DiaSorin Autoimmune Disease Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. DiaSorin Autoimmune Disease Diagnostics Product Portfolio Table 67. DiaSorin Recent Development Table 68. ERBA Diagnostics Company Information Table 69. ERBA Diagnostics Business Overview Table 70. ERBA Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. ERBA Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 72. ERBA Diagnostics Recent Development Table 73. Euro Diagnostica Company Information Table 74. Euro Diagnostica Business Overview Table 75. Euro Diagnostica Autoimmune Disease Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Euro Diagnostica Autoimmune Disease Diagnostics Product Portfolio Table 77. Euro Diagnostica Recent Development Table 78. EUROIMMUN Company Information Table 79. EUROIMMUN Business Overview Table 80. EUROIMMUN Autoimmune Disease Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. EUROIMMUN Autoimmune Disease Diagnostics Product Portfolio Table 82. EUROIMMUN Recent Development Table 83. Exagen Diagnostics Company Information Table 84. Exagen Diagnostics Business Overview Table 85. Exagen Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Exagen Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 87. Exagen Diagnostics Recent Development Table 88. Gold Standard Diagnostics Company Information Table 89. Gold Standard Diagnostics Business Overview Table 90. Gold Standard Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 92. Gold Standard Diagnostics Recent Development Table 93. HOB Diagnostics Company Information Table 94. HOB Diagnostics Business Overview Table 95. HOB Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. HOB Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 97. HOB Diagnostics Recent Development Table 98. HUMAN Diagnostics Company Information Table 99. HUMAN Diagnostics Business Overview Table 100. HUMAN Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. HUMAN Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 102. HUMAN Diagnostics Recent Development Table 103. Immco Diagnostics Company Information Table 104. Immco Diagnostics Business Overview Table 105. Immco Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Immco Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 107. Immco Diagnostics Recent Development Table 108. ImmunArray Company Information Table 109. ImmunArray Business Overview Table 110. ImmunArray Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. ImmunArray Autoimmune Disease Diagnostics Product Portfolio Table 112. ImmunArray Recent Development Table 113. Inova Diagnostics Company Information Table 114. Inova Diagnostics Business Overview Table 115. Inova Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Inova Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 117. Inova Diagnostics Recent Development Table 118. Myriad Genetics Company Information Table 119. Myriad Genetics Business Overview Table 120. Myriad Genetics Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Myriad Genetics Autoimmune Disease Diagnostics Product Portfolio Table 122. Myriad Genetics Recent Development Table 123. Omega Diagnostics Company Information Table 124. Omega Diagnostics Business Overview Table 125. Omega Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Omega Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 127. Omega Diagnostics Recent Development Table 128. ORGENTEC Diagnostika Company Information Table 129. ORGENTEC Diagnostika Business Overview Table 130. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Portfolio Table 132. ORGENTEC Diagnostika Recent Development Table 133. Phadia Company Information Table 134. Phadia Business Overview Table 135. Phadia Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Phadia Autoimmune Disease Diagnostics Product Portfolio Table 137. Phadia Recent Development Table 138. Protagen Company Information Table 139. Protagen Business Overview Table 140. Protagen Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Protagen Autoimmune Disease Diagnostics Product Portfolio Table 142. Protagen Recent Development Table 143. Roche Diagnostics Company Information Table 144. Roche Diagnostics Business Overview Table 145. Roche Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Roche Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 147. Roche Diagnostics Recent Development Table 148. Siemens Healthcare Company Information Table 149. Siemens Healthcare Business Overview Table 150. Siemens Healthcare Autoimmune Disease Diagnostics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Siemens Healthcare Autoimmune Disease Diagnostics Product Portfolio Table 152. Siemens Healthcare Recent Development Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Autoimmune Disease Diagnostics Product Image Figure 2. Global Autoimmune Disease Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Autoimmune Disease Diagnostics Market Size (2021-2032) & (US$ Million) Figure 4. Global Autoimmune Disease Diagnostics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Analyzers Image Figure 8. Assay Kits Image Figure 9. Global Autoimmune Disease Diagnostics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Autoimmune Disease Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Autoimmune Disease Diagnostics Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Research Laboratories Image Figure 14. Global Autoimmune Disease Diagnostics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Autoimmune Disease Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Autoimmune Disease Diagnostics Sales Value Share by Application (2021-2032) Figure 17. Global Autoimmune Disease Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Autoimmune Disease Diagnostics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Autoimmune Disease Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 20. North America Autoimmune Disease Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Autoimmune Disease Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Autoimmune Disease Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Autoimmune Disease Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Autoimmune Disease Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Autoimmune Disease Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 26. South America Autoimmune Disease Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Autoimmune Disease Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Autoimmune Disease Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Analyzers
  • Assay Kits
Applications
  • Hospitals
  • Research Laboratories
Companies covered
  • Abbott Laboratories
  • Autoimmune Technologies
  • Avant Diagnostics
  • Beckman Coulter
  • Bio-Rad Laboratories
  • DiaSorin
  • ERBA Diagnostics
  • Euro Diagnostica
  • EUROIMMUN
  • Exagen Diagnostics
  • Gold Standard Diagnostics
  • HOB Diagnostics
  • HUMAN Diagnostics
  • Immco Diagnostics
  • ImmunArray
  • Inova Diagnostics
  • Myriad Genetics
  • Omega Diagnostics
  • ORGENTEC Diagnostika
  • Phadia
  • Protagen
  • Roche Diagnostics
  • Siemens Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Autoimmune Disease Diagnostics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Autoimmune Disease Diagnostics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Autoimmune Disease Diagnostics Market Dynamics
  1. 2.1 Autoimmune Disease Diagnostics Industry Trends
  2. 2.2 Autoimmune Disease Diagnostics Industry Drivers
  3. 2.3 Autoimmune Disease Diagnostics Industry Opportunities and Challenges
  4. 2.4 Autoimmune Disease Diagnostics Industry Restraints
3 Autoimmune Disease Diagnostics Market by Company
  1. 3.1 Global Autoimmune Disease Diagnostics Company Revenue Ranking in 2025
  2. 3.2 Global Autoimmune Disease Diagnostics Revenue by Company (2021-2026)
  3. 3.3 Global Autoimmune Disease Diagnostics Company Ranking (2024-2026)
  4. 3.4 Global Autoimmune Disease Diagnostics Company Manufacturing Base and Headquarters
  5. 3.5 Global Autoimmune Disease Diagnostics Company Product Type and Application
  6. 3.6 Global Autoimmune Disease Diagnostics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Autoimmune Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Autoimmune Disease Diagnostics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Autoimmune Disease Diagnostics Market by Type
  1. 4.1 Autoimmune Disease Diagnostics Type Introduction
  2. 4.1.1 Analyzers
  3. 4.1.2 Assay Kits
  4. 4.2 Global Autoimmune Disease Diagnostics Sales Value by Type
  5. 4.2.1 Global Autoimmune Disease Diagnostics Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Autoimmune Disease Diagnostics Sales Value by Type (2021-2032)
  7. 4.2.3 Global Autoimmune Disease Diagnostics Sales Value Share by Type (2021-2032)
5 Autoimmune Disease Diagnostics Market by Application
  1. 5.1 Autoimmune Disease Diagnostics Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Research Laboratories
  4. 5.2 Global Autoimmune Disease Diagnostics Sales Value by Application
  5. 5.2.1 Global Autoimmune Disease Diagnostics Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Autoimmune Disease Diagnostics Sales Value by Application (2021-2032)
  7. 5.2.3 Global Autoimmune Disease Diagnostics Sales Value Share by Application (2021-2032)
6 Autoimmune Disease Diagnostics Regional Value Analysis
  1. 6.1 Global Autoimmune Disease Diagnostics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Autoimmune Disease Diagnostics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Autoimmune Disease Diagnostics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Autoimmune Disease Diagnostics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Autoimmune Disease Diagnostics Sales Value (2021-2032)
  7. 6.3.2 North America Autoimmune Disease Diagnostics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Autoimmune Disease Diagnostics Sales Value (2021-2032)
  10. 6.4.2 Europe Autoimmune Disease Diagnostics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Autoimmune Disease Diagnostics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Autoimmune Disease Diagnostics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Autoimmune Disease Diagnostics Sales Value (2021-2032)
  16. 6.6.2 South America Autoimmune Disease Diagnostics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Autoimmune Disease Diagnostics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Autoimmune Disease Diagnostics Sales Value Share by Country, 2025 VS 2032
7 Autoimmune Disease Diagnostics Country-level Value Analysis
  1. 7.1 Global Autoimmune Disease Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Autoimmune Disease Diagnostics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Autoimmune Disease Diagnostics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Autoimmune Disease Diagnostics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Autoimmune Disease Diagnostics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Autoimmune Disease Diagnostics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Autoimmune Disease Diagnostics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Autoimmune Disease Diagnostics Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Autoimmune Technologies
  8. 8.2.1 Autoimmune Technologies Company Information
  9. 8.2.2 Autoimmune Technologies Business Overview
  10. 8.2.3 Autoimmune Technologies Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Autoimmune Technologies Autoimmune Disease Diagnostics Product Portfolio
  12. 8.2.5 Autoimmune Technologies Recent Developments
  13. 8.3 Avant Diagnostics
  14. 8.3.1 Avant Diagnostics Company Information
  15. 8.3.2 Avant Diagnostics Business Overview
  16. 8.3.3 Avant Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Avant Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  18. 8.3.5 Avant Diagnostics Recent Developments
  19. 8.4 Beckman Coulter
  20. 8.4.1 Beckman Coulter Company Information
  21. 8.4.2 Beckman Coulter Business Overview
  22. 8.4.3 Beckman Coulter Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Beckman Coulter Autoimmune Disease Diagnostics Product Portfolio
  24. 8.4.5 Beckman Coulter Recent Developments
  25. 8.5 Bio-Rad Laboratories
  26. 8.5.1 Bio-Rad Laboratories Company Information
  27. 8.5.2 Bio-Rad Laboratories Business Overview
  28. 8.5.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Portfolio
  30. 8.5.5 Bio-Rad Laboratories Recent Developments
  31. 8.6 DiaSorin
  32. 8.6.1 DiaSorin Company Information
  33. 8.6.2 DiaSorin Business Overview
  34. 8.6.3 DiaSorin Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 DiaSorin Autoimmune Disease Diagnostics Product Portfolio
  36. 8.6.5 DiaSorin Recent Developments
  37. 8.7 ERBA Diagnostics
  38. 8.7.1 ERBA Diagnostics Company Information
  39. 8.7.2 ERBA Diagnostics Business Overview
  40. 8.7.3 ERBA Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ERBA Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  42. 8.7.5 ERBA Diagnostics Recent Developments
  43. 8.8 Euro Diagnostica
  44. 8.8.1 Euro Diagnostica Company Information
  45. 8.8.2 Euro Diagnostica Business Overview
  46. 8.8.3 Euro Diagnostica Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Euro Diagnostica Autoimmune Disease Diagnostics Product Portfolio
  48. 8.8.5 Euro Diagnostica Recent Developments
  49. 8.9 EUROIMMUN
  50. 8.9.1 EUROIMMUN Company Information
  51. 8.9.2 EUROIMMUN Business Overview
  52. 8.9.3 EUROIMMUN Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EUROIMMUN Autoimmune Disease Diagnostics Product Portfolio
  54. 8.9.5 EUROIMMUN Recent Developments
  55. 8.10 Exagen Diagnostics
  56. 8.10.1 Exagen Diagnostics Company Information
  57. 8.10.2 Exagen Diagnostics Business Overview
  58. 8.10.3 Exagen Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Exagen Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  60. 8.10.5 Exagen Diagnostics Recent Developments
  61. 8.11 Gold Standard Diagnostics
  62. 8.11.1 Gold Standard Diagnostics Company Information
  63. 8.11.2 Gold Standard Diagnostics Business Overview
  64. 8.11.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  66. 8.11.5 Gold Standard Diagnostics Recent Developments
  67. 8.12 HOB Diagnostics
  68. 8.12.1 HOB Diagnostics Company Information
  69. 8.12.2 HOB Diagnostics Business Overview
  70. 8.12.3 HOB Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 HOB Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  72. 8.12.5 HOB Diagnostics Recent Developments
  73. 8.13 HUMAN Diagnostics
  74. 8.13.1 HUMAN Diagnostics Company Information
  75. 8.13.2 HUMAN Diagnostics Business Overview
  76. 8.13.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 HUMAN Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  78. 8.13.5 HUMAN Diagnostics Recent Developments
  79. 8.14 Immco Diagnostics
  80. 8.14.1 Immco Diagnostics Company Information
  81. 8.14.2 Immco Diagnostics Business Overview
  82. 8.14.3 Immco Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Immco Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  84. 8.14.5 Immco Diagnostics Recent Developments
  85. 8.15 ImmunArray
  86. 8.15.1 ImmunArray Company Information
  87. 8.15.2 ImmunArray Business Overview
  88. 8.15.3 ImmunArray Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ImmunArray Autoimmune Disease Diagnostics Product Portfolio
  90. 8.15.5 ImmunArray Recent Developments
  91. 8.16 Inova Diagnostics
  92. 8.16.1 Inova Diagnostics Company Information
  93. 8.16.2 Inova Diagnostics Business Overview
  94. 8.16.3 Inova Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Inova Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  96. 8.16.5 Inova Diagnostics Recent Developments
  97. 8.17 Myriad Genetics
  98. 8.17.1 Myriad Genetics Company Information
  99. 8.17.2 Myriad Genetics Business Overview
  100. 8.17.3 Myriad Genetics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Myriad Genetics Autoimmune Disease Diagnostics Product Portfolio
  102. 8.17.5 Myriad Genetics Recent Developments
  103. 8.18 Omega Diagnostics
  104. 8.18.1 Omega Diagnostics Company Information
  105. 8.18.2 Omega Diagnostics Business Overview
  106. 8.18.3 Omega Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Omega Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  108. 8.18.5 Omega Diagnostics Recent Developments
  109. 8.19 ORGENTEC Diagnostika
  110. 8.19.1 ORGENTEC Diagnostika Company Information
  111. 8.19.2 ORGENTEC Diagnostika Business Overview
  112. 8.19.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  113. 8.19.4 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Portfolio
  114. 8.19.5 ORGENTEC Diagnostika Recent Developments
  115. 8.20 Phadia
  116. 8.20.1 Phadia Company Information
  117. 8.20.2 Phadia Business Overview
  118. 8.20.3 Phadia Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Phadia Autoimmune Disease Diagnostics Product Portfolio
  120. 8.20.5 Phadia Recent Developments
  121. 8.21 Protagen
  122. 8.21.1 Protagen Company Information
  123. 8.21.2 Protagen Business Overview
  124. 8.21.3 Protagen Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Protagen Autoimmune Disease Diagnostics Product Portfolio
  126. 8.21.5 Protagen Recent Developments
  127. 8.22 Roche Diagnostics
  128. 8.22.1 Roche Diagnostics Company Information
  129. 8.22.2 Roche Diagnostics Business Overview
  130. 8.22.3 Roche Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Roche Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  132. 8.22.5 Roche Diagnostics Recent Developments
  133. 8.23 Siemens Healthcare
  134. 8.23.1 Siemens Healthcare Company Information
  135. 8.23.2 Siemens Healthcare Business Overview
  136. 8.23.3 Siemens Healthcare Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Siemens Healthcare Autoimmune Disease Diagnostics Product Portfolio
  138. 8.23.5 Siemens Healthcare Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst